Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study
Anderson, Deverick J, Dr, Chen, Luke F, MBBS, Weber, David J, Prof, Moehring, Rebekah W, MD, Lewis, Sarah S, MD, Triplett, Patricia F, MD, Blocker, Michael, MD, Becherer, Paul, MD, Schwab, J Conrad, MD, Knelson, Lauren P, MSPH, Lokhnygina, Yuliya, PhD, Rutala, William A, PhD, Kanamori, Hajime, MD, Gergen, Maria F, MT ASCP, Sexton, Daniel J, Prof
Published in The Lancet (British edition) (25.02.2017)
Published in The Lancet (British edition) (25.02.2017)
Get full text
Journal Article